Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Liver fibrosis occurs following inflammation triggered by the integrated actions of activated liver-resident macrophages (Kupffer cells) and hepatic stellate cells (HSCs), and the multiplicity of these mechanisms complicates drug therapy. Here, we demonstrate that the selective bromodomain and extra-terminal (BET) bromodomain inhibitor compound38 can block both the Janus kinase-signal transducer and activator of transcription and mitogen-activated protein kinase signaling pathways in macrophages, which decreased their secretion of proinflammatory cytokines in a dose-dependent manner. The inactivation of macrophages attenuated lipopolysaccharide-induced injurious inflammation concurrent with a reduction in F4/80+ cells, proinflammatory cytokine levels, and neutrophil infiltration. Moreover, compound 38 inhibited the Wnt/β-catenin and transforming growth factor-beta/SMAD signaling pathways to abolish the activation of HSCs. In vivo, compound 38 significantly decreased the collagen deposition and fibrotic area of a CCl4-induced liver fibrosis model, and restored the deficiency of activated HSCs and the upregulation of liver inflammation. These results highlight the potential role of compound 38 in treating liver fibrosis considering its simultaneous inhibitory effects on liver inflammation and related fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, inhibition of ERK/AKT, IRF5, JAK1/JAK2-STAT1, MAP kinase and Notch1 signaling pathways consistently promotes restorative macrophages polarization and attenuates fibrogenic responses (47–55).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“0 software to investigate the variance in specific gene sets [45].”
MethodCytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“0 and Cytoscape to determine the proteinprotein interactions (PPIs) [46,47].”
BackgroundSTAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“The edgeR package was used to perform differential gene expression analysis [43].”
MethodclusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · cited 1×
“8 bioinformatics platform and ClusterProfiler R package were further used to explore the biological functions associated with the differentially expressed genes [44].”
MethodfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · cited 1×
“5 was used to map the sequencing reads to the mm10 reference, and featurecounts software was used to quantify the gene expression [41,42].”
MethodSzklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“0 and Cytoscape to determine the proteinprotein interactions (PPIs) [46,47].”
BackgroundThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 1×
“Kupffer cells are liver macrophages whose functions are highly specialized and different from those of other anatomical sites [49,50].”
BackgroundMyofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 3×
“The activation of HSCs has been considered as the critical trigger of liver fibrosis in humans and in experimental liver injury models [7].”
Background
Cited by
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Zhang, Y., Ren, L., Tian, Y., Guo, X., Fengxian, W., & Zhang, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1454980 · Cited by 93
Self-citationPharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Zhao, L., Tang, H., & Cheng, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17121724 · Cited by 40
“Some, such as JQ1, I-BET151 (GSK1210151A), and Compound 38, have been studied and shown to improve liver fibrosis, demonstrating strong preclinical and clinical potential [67–69].”
BRD4: an effective target for organ fibrosis
Wei, Q., Gan, C., Sun, M., Xie, Y., Liu, H., Xue, T., Deng, C., Mo, C., & Ye, T. (2024) · Biomarker Research · doi:10.1186/s40364-024-00641-6 · Cited by 34
Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
Morgado‐Pascual, J. L., Suárez-Álvarez, B., Marchant, V. A., Basantes, P. E., Tharaux, P., Ortíz, A., López‐Larrea, C., Ruiz‐Ortega, M., & Rayego‐Mateos, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010486 · Cited by 19
“Indeed, in liver injury, iBET blocked TGFβ/SMAD signaling to inactivate hepatic stellate cells [82].”
BackgroundThe epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts
Dudakovic, A., Bayram, B., Bettencourt, J. W., Limberg, A. K., Galvan, M. L., Carrasco, M. E., Stans, B., Thaler, R., Morrey, M. E., Sánchez‐Sotelo, J., et al. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30368 · Cited by 9
“Interestingly, it has been shown that targeting of BET proteins may also exert anti‐fibrotic activities by reducing the activation of the inflammatory cascade.(71,72) The connection between inflammation, fibrosis, and BET proteins is especially of interest to our group as our studies have previously shown that targeti…”
Background
Metadata
- Authors
- Fu, R., Zu, S.-J., Liu, Y.-J., Li, J.-C., Dang, W.-Z., Liao, L.-P., Liu, L.-P., Chen, P.-Y., Huang, H.-M., Wu, K.-H., Zhou, B., Pan, Q., Luo, C., Zhang, Y.-Y., & Li, G.-M.
- Affiliations
- Shanghai Jiao Tong University (CN)
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, Zuchongzhi District, Shanghai, China
- Chinese Academy of Sciences (CN)
- Department of Gastroenterology, Xinhua Hospital, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Yangpu District, China
- Venue
- Bioengineered
- Publisher
- Informa UK Limited
- Published
- 2022-04-01
- Volume
- 13
- Issue
- 4
- Pages
- 10914-10930
- ISSN
- 2165-5979 (ISSN-L)
- 2165-5987
- PMC
- PMC9278415
- OpenAlex
- W4225274129
- Cited by
- 12
- References
- 68
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Bioengineered (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82170617)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- liver fibrosis, liver inflammation, Kupffer cells, hepatic stellate cells, BET bromodomain, JAK/STAT signaling, MAPK signaling, Wnt/β-catenin signaling, TGF-β/Smad signaling, inflammatory cytokines, neutrophil infiltration, collagen deposition, CCl4-induced fibrosis
- MeSH terms
- Humans, Inflammation, Liver Cirrhosis, Macrophages, Cytokines, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis. https://app.cochat.ai/papers/10.1080/21655979.2022.2066756
- The paper
- Fu, R., Zu, S.-J., Liu, Y.-J., Li, J.-C., Dang, W.-Z., Liao, L.-P., Liu, L.-P., Chen, P.-Y., Huang, H.-M., Wu, K.-H., Zhou, B., Pan, Q., Luo, C., Zhang, Y.-Y., & Li, G.-M. (2022). Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis. Bioengineered. https://doi.org/10.1080/21655979.2022.2066756
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.